Safety concerns and health benefits associated with oral contraception.

作者: Ronald Burkman , James J. Schlesselman , Miriam Zieman

DOI: 10.1016/J.AJOG.2004.01.061

关键词:

摘要: Since the introduction of hormonal contraceptives in 1960s, there have been a variety both health benefits and safety concerns attributed to their use. In most instances, noncontraceptive oral (OCs) outweigh potential cardiovascular risks. fact, probability patient experiencing event while taking low-dose OC is very low. However, smoking, hypertension, obesity, diabetes are risk factors that must be taken into account when prescribing OCs. The neoplastic effects extensively studied, recent meta-analyses indicate reduction endometrial ovarian cancer, possible small increase for breast cervical an increased liver cancer. Finally, many women will experience with OCs expand far beyond pregnancy prevention. Some these include menstrual-related symptoms, fewer ectopic pregnancies, bone density, protection against pelvic inflammatory disease.

参考文章(99)
Chi-Ling Chen, Hormone Replacement Therapy in Relation to Breast Cancer JAMA. ,vol. 287, pp. 734- 741 ,(2002) , 10.1001/JAMA.287.6.734
Ronald L. Young, Michael C. Snabes, Margaret L. Frank, Maryanne Reilly, A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development. American Journal of Obstetrics and Gynecology. ,vol. 167, pp. 678- 682 ,(1992) , 10.1016/S0002-9378(11)91570-1
Thomas E. Rohan, Anthony B. Miller, A cohort study of oral contraceptive use and risk of benign breast disease. International Journal of Cancer. ,vol. 82, pp. 191- 196 ,(1999) , 10.1002/(SICI)1097-0215(19990719)82:2<191::AID-IJC7>3.0.CO;2-F
J.P. Deslypere, M. Thiery, A. Vermeulen, EFFECT OF LONG-TERM HORMONAL CONTRACEPTION ON PLASMA LIPIDS Contraception. ,vol. 31, pp. 633- 642 ,(1985) , 10.1016/0010-7824(85)90063-0
Herbert B. Peterson, Nancy C. Lee, The health effects of oral contraceptives: misperceptions, controversies, and continuing good news. Clinical Obstetrics and Gynecology. ,vol. 32, pp. 339- 355 ,(1989) , 10.1097/00003081-198906000-00019
G REDMOND, W OLSON, J LIPPMAN, M KAFRISSEN, T JONES, J JORIZZO, Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstetrics & Gynecology. ,vol. 89, pp. 615- 622 ,(1997) , 10.1016/S0029-7844(97)00059-8
Gerd Larsson, Lan Milsom, Göran Lindstedt, Göran Rybo, The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status. Contraception. ,vol. 46, pp. 327- 334 ,(1992) , 10.1016/0010-7824(92)90095-B